Singapore markets open in 6 hours 3 minutes
Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,299.85 +53.17 (+1.01%) Dow
39,829.82 +271.71 (+0.69%) Nasdaq
16,726.25 +215.07 (+1.30%) Bitcoin USD
65,341.63 +3,966.22 (+6.46%) CMC Crypto 200
1,380.92 +112.98 (+8.92%)
Dyne Therapeutics, Inc. (DYN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:56PM EDT. Market open.
Loading interactive chart…
- Simply Wall St.
We're Hopeful That Dyne Therapeutics (NASDAQ:DYN) Will Use Its Cash Wisely
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- GuruFocus.com
Dyne Therapeutics Inc (DYN) Q1 2024 Earnings: Aligns with Analyst Projections
Overview of Financial Performance and Future Prospects
- GlobeNewswire
Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
- Additional Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Anticipated in the Second Half of 2024 - WALTHAM, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today reported financial results for the first quarter of 2024 and recent business highlights. “I am excited about
© 2024 Yahoo. All rights reserved.